Breast disorders

Guidelines (7)

Everolimus in Combination with Exemestane for Treating Advanced HER2-Negative Hormone-Receptor-Positive Breast Cancer after Endocrine Therapy (TA295)

28 August 2013

Bevacizumab in Combination with Capecitabine for the First-Line Treatment of Metastatic Breast Cancer (TA263)

24 August 2012

Lapatinib or Trastuzumab in Combination with an Aromatase Inhibitor for the First-Line Treatment of Metastatic Hormone-Receptor-Positive Breast Cancer that Overexpresses HER2 (TA257)

27 July 2012

Eribulin for the Treatment of Locally Advanced or Metastatic Breast Cancer (TA250)

23 April 2012

Bevacizumab in Combination with a Taxane for the First-Line Treatment of Metastatic Breast Cancer (TA214)

17 March 2011

Cancer, Breast (Early): Hormonal Therapies (NICE)

4 October 2007

Cancer, Breast (Metastatic): Gemcitabine (NICE)

3 October 2007

Drug Sections (1)

Breast disorders in the News

Kadcyla: a new option in locally advanced or metastatic breast cancer

Kadcyla: a new option in locally advanced or metastatic breast cancer

2 January 2014

Kadcyla (trastuzumab emtansine) is indicated in HER2-positive,...

Herceptin now available for subcutaneous injection

Herceptin now available for subcutaneous injection

1 November 2013

A subcutaneous formulation of the breast cancer treatment...

All Women's Health Patient Fact Sheets

5 March 2007

Printable fact sheets providing your female patients...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.